{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "490984d1-16ce-46c5-b0e9-0f1456c6a9c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import Pkg; Pkg.add(\"Plots\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c6060440-e68c-4540-b9e9-87e088683855",
   "metadata": {},
   "outputs": [],
   "source": [
    "using DifferentialEquations, Plots"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ec3b2d06-c9ec-46bf-9851-ee7ab18ccbec",
   "metadata": {},
   "outputs": [],
   "source": [
    "function I_eff(I, Aβ, τ, K_R, K_τ)\n",
    "    \"\"\" Multiplicative competitive inhibition.\n",
    "\n",
    "    Masking of insulin receptors by Aβ & tau.\n",
    "    Aβ oligomers block IR binding; p-tau blocks downstream signalling.\n",
    "    Uses two independent competitive terms multiplied (equivalent to adding free energies of inhibition).\n",
    "    \"\"\"\n",
    "    inhibitors = (1 + (Aβ / K_R)) * (1 + (τ / K_τ))\n",
    "    return I / inhibitors \n",
    "end"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1045fb86-d708-4544-8cef-4aa1aed51055",
   "metadata": {},
   "outputs": [],
   "source": [
    "function V_ide(I, V_0, K_ρ, ρ)\n",
    "    \"\"\" Michaelis-Menten-like regulatory rise.\n",
    "\n",
    "    Insulin-dependent IDE induction.\n",
    "    The maximum catalytic capacity of IDE increases with insulin signalling until a new plateau (V0(1+ρ)V0​(1+ρ)).\n",
    "    Standard hyperbolic activation; no change.\n",
    "    \"\"\"\n",
    "    return V_0 * (1 + ρ * (I / (K_ρ + I)))\n",
    "end"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d8ed1651-b294-4ce0-a31d-0384a2e257f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "function rm3!(du, u, p, t)\n",
    "    I, Aβ, τ = u\n",
    "    S_0, S_Aβ_0, K_BBB, K_Aβ, K_I, K_ρ, K_R, K_τ, k_clr, k_phos, k_dephos, S_Aβ, I_50, σ, μ, γ, ρ, n = p\n",
    "\n",
    "    \"\"\"\n",
    "    first term: Insulin transport brake. Michaelis-Menten inhibition of a source term.\n",
    "    - Brain uptake of plasma insulin slows as interstitial insulin climbs (saturable BBB transporter).\n",
    "    - Same algebraic structure as MM, but applied to a supply flux rather than a clearance flux.\n",
    "\n",
    "    second term: Linear (first-order) clearance.\n",
    "    - Non-IDE clearance routes.\n",
    "\n",
    "    third term: IDE-mediated clearance. Competitive Michaelis-Menten.\n",
    "    - Insulin is removed by insulin-degrading enzyme at a rate that saturates with its own\n",
    "    concentration and is competitively slowed by the other substrate.\n",
    "    - Only change from the classic form is that Vmax⁡ itself is allowed to depend on II (see next row).\n",
    "    \"\"\"\n",
    "    I_dot = (S_0 / (1 + (I / K_BBB))) - k_clr*I - (V_ide(I, V_0, K_ρ, ρ)*I / K_I*(1 + (Aβ / K_Aβ) + I))\n",
    "\n",
    "    \"\"\"\n",
    "    first term: basal influx minus direct anti-amyloid action of insulin. Linear mass-action.\n",
    "    - Higher insulin pushes APP down the non-amyloidogenic route, lowering Aβ production.\n",
    "    - No novelty; included because review 3 explicitly documents the effect.\n",
    "\n",
    "    second term: Linear (first-order) clearance.\n",
    "    - Non-IDE clearance routes.\n",
    "\n",
    "    third term: IDE-mediated clearance. Competitive Michaelis-Menten.\n",
    "    - Aβ is removed by insulin-degrading enzyme at a rate that saturates with its own\n",
    "    concentration and is competitively slowed by the other substrate.\n",
    "    - Only change from the classic form is that Vmax⁡ itself is allowed to depend on II (see next row).\n",
    "\n",
    "    fourth term: IDE crowding by insulin in Aβ branch. Competitive modifier grafted onto the Aβ MM term.\n",
    "    - When insulin hogs IDE, Aβ clearance is further slowed.\n",
    "    - Minor deviation: instead of placing II in both the numerator & denominator, we simply multiply by\n",
    "    the fractional unoccupied IDE.\n",
    "    \"\"\"\n",
    "    Aβ_dot = (S_Aβ_0 - σ*I) - μ*Aβ - (V_ide(I, V_0, K_ρ, ρ)*Aβ / (K_Aβ + Aβ)) * (1 / (1 + (I / K_I)))\n",
    "\n",
    "    \"\"\"\n",
    "    first term: Kinase inhibition by insulin. Hill function (sigmoidal repression).\n",
    "    - Active glycogen-synthase-kinase-3β (and JNK) fraction falls as functional insulin rises.\n",
    "    - Exactly the textbook Hill form; nn tunes ultrasensitivity.\n",
    "\n",
    "    second term: Aβ-driven tau‐P surge. Linear drive.\n",
    "    - Oligomeric Aβ elevates tau phosphorylation via TNFα–JNK → IRS-1 blockade.\n",
    "    - Kept linear: reviews give no evidence for saturation within physiological Aβ range.\n",
    "\n",
    "    third term: Linear (first-order) clearance.\n",
    "    - Constitutive dephosphorylation\n",
    "    \n",
    "    \"\"\"\n",
    "    τ_dot = k_phos*(1 / (1 + (I_eff(I, Aβ, τ, K_R, K_τ) / I_50)^n)) + γ*Aβ - k_dephos*τ\n",
    "\n",
    "    du[1] = I_dot\n",
    "    du[2] = Aβ_dot\n",
    "    du[3] = τ_dot\n",
    "end"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6b2fa2ff-9fb3-49cc-98a1-67dda3347e8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "u0 = [1.0; 0.5; 0.5]\n",
    "tspan = (0.0, 1000.0)\n",
    "\n",
    "\"\"\"units\n",
    "T: hour (h)\n",
    "C: micromole (μM * Liter)\n",
    "\"\"\"\n",
    "\n",
    "\"\"\" basal values, anchor linear supply processes.\n",
    "Zero-order synthesis / influx rates (fluxes) independent of the state variables.\n",
    "\n",
    "They feed material into the system. We kept the S-notation to flag parameters you’d\n",
    "normally get from uptake or secretion assays rather than from binding kinetics.\n",
    "\n",
    "concentration · time−1−1 (e.g., μM h−1−1)\n",
    "\"\"\"\n",
    "S_0 = 0.12        # μM⋅h^{-1] Maximal plasma‐to‑brain insulin flux (post‑prandial peak). 2/4\n",
    "S_Aβ_0 = 0.005    # μM⋅h^{-1} −1\tNeuronal APP shedding gives ~0.5 pmol h−1−1 mg−1−1 protein; scaled to tissue. 2/4\n",
    "\n",
    "# basal max IDE rate\n",
    "V_0 = 5.0         # μM⋅h^{-1} Microdialysis turnover fit 2/4\n",
    "\n",
    "\"\"\" Affinity/threshold constants in denominator-type terms (MM, Hill, competition), anchor non-linear saturation or competition.\n",
    "\n",
    "Numerically they are points at which the denominator doubles.\n",
    "In enzymology & regulatory kinetics, capital KK traditionally marks a binding constant or a half-effect concentration.\n",
    "\n",
    "Same as species they relate to (μM, nM…)\n",
    "\"\"\"\n",
    "K_BBB = 0.5       # μM Saturation constant for insulin transporter; set near upper CSF insulin during euglycaemic clamp. 2/4\n",
    "K_Aβ = 0.3        # μM Same paper, Aβ as substrate, IDE affinity for Aβ 3/4\n",
    "K_I = 1.0         # μM IDE kinetics (rat brain cytosol), IDE affinity for insulin 3/4\n",
    "K_ρ = 0.50        # μM IDE transcription half‑max by insulin (hepatocyte & neuron culture). 2/4\n",
    "K_R = 0.10        # μM Aβ dimer concentration giving 50 % IR inhibition (binding assays). 2/4\n",
    "K_τ = 0.05        # p‑tau concentration giving 50 % IRS‑1 blockade (cell culture). 2/4\n",
    "\n",
    "# rate constants\n",
    "k_clr = 0.20      # h^{-1} Brain interstitial insulin T1/2 ≈ 3.5 h ⇒ k = ln 2 / 3.5 h. 3/4\n",
    "k_phos = 0.05     # h^{-1} In-vitro tau-P time course 3/4\n",
    "k_dephos = 0.02   # h^{-1} PP2A activity assays 3/4\n",
    "\n",
    "\"\"\" half-maximal inhibitory concentration of functional insulin for the kinase block that limits tau phosphorylation.\n",
    "\n",
    "Mathematically it is the value of IeffIeff​ at which the Hill factor drops to 1/2.\n",
    "Biologically it aggregates two empirical numbers measured in the literature:\n",
    "- the concentration needed to activate Akt strongly enough to inhibit GSK-3β, plus\n",
    "- the concentration that restrains JNK via IRS-1 serine de-phosphorylation.\n",
    "\"\"\"\n",
    "I_50 = 0.0002     # 0.2 nM, 50 % Akt/GSK‑3β block 3/4\n",
    "\n",
    "σ = 0.010         # h^{-1} Insulin‑driven shift to non‑amyloidogenic APP (10 % of baseline Aβ generation per µM insulin). 2/4\n",
    "μ = 0.010         # h^{-1} Bulk Aβ proteolysis / drainage half‑life ≈ 70 h. 3/4\n",
    "γ = 0.050         # h^{-1} Strength of Aβ‑induced tau phosphorylation (p‑tau doubling in ≈ 14 h when Aβ ≈ 1 µM). 2/4\n",
    "ρ = 1.0           # PI3K-IDE induction assays, IDE Vmax⁡ doubling 2/4\n",
    "\n",
    "# hill factor\n",
    "n = 3.0           # Typical GSK-3β ultrasensitivity, hill coefficient, 3/4\n",
    "\n",
    "p = [S_0; S_Aβ_0; V_0; K_BBB; K_Aβ; K_I; K_ρ; K_R; K_τ; k_clr; k_phos; k_dephos; I_50; σ; μ; γ; ρ; n]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4b97e3a0-2949-4cee-9aaf-3e699df55336",
   "metadata": {},
   "outputs": [],
   "source": [
    "prob = ODEProblem(rm3!, u0, tspan, p)\n",
    "sol = solve(prob)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f97e2d3d-8287-4fba-876e-25322678e86f",
   "metadata": {},
   "outputs": [],
   "source": [
    "plot(sol)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a0da7642-35c8-4713-aa9f-d41485f2070f",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "654fe195-1f5e-4326-a556-e20c14e1f3d3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Julia 1.11.3",
   "language": "julia",
   "name": "julia-1.11"
  },
  "language_info": {
   "file_extension": ".jl",
   "mimetype": "application/julia",
   "name": "julia",
   "version": "1.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
